Literature DB >> 14764989

The functional interactions between the p53 and MAPK signaling pathways.

Gen Sheng Wu1.   

Abstract

The p53 tumor suppressor protein exerts its growth inhibitory activity by activating and interacting with diverse signaling pathways. As a downstream target, p53 protein is phosphorylated and activated by a number of protein kinases in response to stressful stimuli. As an upstream activator, activated p53 acts as a transcription factor to induce and/or suppress a number of genes whose expression leads to the activation of diverse signaling pathways. p53 protein can also interact with a number of proteins, resulting in an increase or decrease in p53 activity itself. The activation of p53 leads to many outcomes in cells, including cell cycle arrest and apoptosis. It has become clear that the p53 protein can functionally interact with the mitogen-activated protein kinase (MAPK) pathways, including the stress-activated protein kinase [SAPK/c-Jun N-terminal protein kinase (JNK)], the p38 mitogen-activated protein kinase (MAPK), and the extracellular signal related kinase (ERK). Upon exposure to stressful stimuli, MAP kinases phosphorylate and activate p53, leading to p53-mediated cellular responses. Recent studies have suggested a role of p53 as an upstream activator to regulate MAPK signaling via the transcriptional activation of members of the dual specificity phosphatase family. Because both the p53 and MAPK signaling pathways are altered in the majority of human tumors, understanding their functional interaction may provide new insights into the deregulated cell proliferation and survival that is characteristic of cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764989     DOI: 10.4161/cbt.3.2.614

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  107 in total

1.  Ultraviolet irradiation-induced K(+) channel activity involving p53 activation in corneal epithelial cells.

Authors:  Ling Wang; Wei Dai; Luo Lu
Journal:  Oncogene       Date:  2005-04-21       Impact factor: 9.867

2.  Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells.

Authors:  Jian-Ming Sun; Li-Na Yang; Han Xu; Bin Chang; Hua-Ying Wang; Gong Yang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Inhibitor of p53-p21 pathway induces the differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyogenic cells.

Authors:  Zhong-Bao Ruan; Li Zhu; Yi-Gang Yin; Ge-Cai Chen
Journal:  Cytotechnology       Date:  2015-06-05       Impact factor: 2.058

4.  AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.

Authors:  Anna de Polo; Zhongling Luo; Casimiro Gerarduzzi; Xiang Chen; John B Little; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

5.  Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway.

Authors:  Wayne Chris Hawkes; Zeynep Alkan
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

6.  Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells.

Authors:  Dongli Yang; Susan G Elner; Zong-Mei Bian; Gerd O Till; Howard R Petty; Victor M Elner
Journal:  Exp Eye Res       Date:  2007-06-27       Impact factor: 3.467

7.  Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.

Authors:  L Sauer; D Gitenay; C Vo; V T Baron
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

8.  Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy.

Authors:  Juan Wang; Jun-Ying Zhou; Dhonghyo Kho; John J Reiners; Gen Sheng Wu
Journal:  Autophagy       Date:  2016-07-26       Impact factor: 16.016

9.  Targeting cancer cells with the natural compound obtusaquinone.

Authors:  Christian E Badr; Stephanie Van Hoppe; Hawasatu Dumbuya; Lee-Ann Tjon-Kon-Fat; Bakhos A Tannous
Journal:  J Natl Cancer Inst       Date:  2013-03-11       Impact factor: 13.506

Review 10.  Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.

Authors:  Jacqueline Whyte; Orla Bergin; Alessandro Bianchi; Sara McNally; Finian Martin
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.